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ABSTRACT
Primary cilia arebiophysically-sensitive organelles responsible for sensing fluid-flow and transducing this stimulus into intracellular responses. Previous studies have
shown that the primary cilia mediate flow-induced calcium influx, and sensitivity of cilia function to flow is correlated to cilia length. Cells with abnormal cilia length
or function can lead to a host of diseases that are collectively termed as ciliopathies. Rapamycin, a potent inhibitor of mTOR (mammalian target of rapamycin), has
been demonstrated to be a potential pharmacological agent against the aberrant mTOR signaling seen in ciliopathies such as polycystic kidney disease (PKD) and
tuberous sclerosis complex (TSC). Here we look at the effects of rapamycin on ciliary length and function for the first time. Compared to controls, primary cilia in
rapamycin-treated porcine renal epithelial and mouse vascular endothelial cells showed a significant increase in length. Graded increases in fluid-shear stress further
indicates that rapamycin enhances cilia sensitivity to fluid flow. Treatment with rapamycin led to G0 arrest in porcine epithelial cells while no significant change in
cell cycle were observed in rapamycin-treated mouse epithelial or endothelial cells, indicating a species-specific effect of rapamycin. Given the previousin vitro and in
vivo studies establishing rapamycin as a potential therapeutic agent for ciliopathies, such as PKD and TSC, our studies show that rapamycin enhances ciliary function
and sensitivity to fluid flow. The results of our studies suggest a potential ciliotherapeutic effect of rapamycin.
KEYWORDS: cilium, kidney, mechanosensation, shear-stress, vascular.
Introduction
The primary cilium is a solitary cellular organelle that protrudes from the apical
cell membrane. Studies on cilia-dependent mechanosenstation have shown that
the primary cilium acts as a transducer of fluid-shear stress into intracellular signaling (Masyuk et al., 2006, Nauli et al., 2003, Nauli et al., 2008). Along with its
mechanosensory function, the primary cilium houses a variety of receptors, ion
channels, transporter proteins, and other protein complexes involved in signal
transductions, such as the Hedgehog(Huang and Schier, 2009),Wnt (Corbit et
al., 2005), planar cell polarity (Ross et al., 2005) and platelet-derived growth factor(Schneider et al., 2005)pathways.
Abnormalities in cilia structure or function lead to a spectrum of diseases called
ciliopathies. Ciliopathies can affect a variety of organs due to the ubiquitous presence of primary cilia in different organ systems and their role as a signaling hub
(Lancaster and Gleeson, 2009). The mechanosensory function of primary cilia
occurs in various organs, such as renal nephron (Nauli et al., 2006, Siroky et al.,
2006, Liu et al., 2005), hepatic biliary system (Masyuk et al., 2006), pancreatic
duct (Cano et al., 2006) and vasculature (Abou Alaiwi et al., 2011, AbouAlaiwi et
al., 2009). Shortened primary cilia have been shown to result in polycystic kidneys (Lin et al., 2003, Yoder et al., 1995), and a reduction in mechanosensory
function of the cilia has also been reported to promote polycystic kidney phenotypes (Aboualaiwi et al., 2014, Nauli et al., 2008, Nauli et al., 2003). The ability
to sense and respond to extracellular simulation is thought to be the basis for
homeostatic adaptation and critical for normal development of various organs.
When the primary cilium is dysfunction, cells cannot respond properly to environmental cues leading to ciliopathy phenotypes.
The primary cilium responds to flow-induced bending with calcium entry
through mechanically sensitive channels. Studies have shown that bending of the
cilium in cultured cells results in an increase in intracellular calcium concentration (Jin et al., 2014, Praetorius and Spring, 2001). The large increase in
cytosolic calcium may activate calcium dependent processes that range from cell
proliferation to cell death(Berridge et al., 2000).For this reason, calcium
fluorimetry has been used as a means of quantifying cilia function, i.e. response
to fluid-shear stress (Liu et al., 2005, Siroky et al., 2006)and pharmacological
agents (Kathem et al., 2014, Abdul-Majeed and Nauli, 2011).
Polycystic kidney disease (PKD) has been associated to the inability of renal
epithelia (Xu et al., 2007) or vascular endothelia (Nauli et al., 2008) to carry out a
calcium influx in response to fluid-flow. Aberrant activation of mTOR (mammalian target of rapamycin) has also been reported in PKD(Shillingford et al.,
2010, Shillingford et al., 2006, Pema et al., 2016). The loss of function in the
TSC complex has been associated with development of renal cysts (Armour et
al., 2012, Bonnet et al., 2009). In normal cells, the cilia regulate the mTOR pathway through polycystin-1 (PC1) mediated suppression. PC1 is localized to the
cilia and is critical in the formation of the polycystin flow-sensing complex in the
cilia. When PC1 is inactivated, cyst-lining epithelial cells show activation of
mTOR as measured by phosphorylation of mTOR and S6 kinase, a downstream
effector. This has led to the use of mTOR inhibitors, such as rapamycin, as potential drug candidate to target the aberrant mTOR activation in PKD.

Although the role of rapamycin on cilia length and function has never been studied, mTOR pathway may modulate cilia length and function, pointing to a potential effect of rapamycin on cilia length and function(Yuan et al., 2012). The relationship between mTOR and cilia also suggests that primary cilia are dynamic
organelles that can be modulated through the mTOR intracellular signaling pathways. Becausein vivo evidence has shown that rapamycin can reduce cyst
growth and preserve renal function (Stayner et al., 2012, Shillingford et al.,
2010, Tao et al., 2005), our present study aims to examine the effects of
rapamycin-induced changes in cilia length and function. Our studies further evaluate if rapamycin would have an effect in vascular system in addition to the kidney. The use rapamycin also offers positive outcomes in different species,
including mouse, rat, and pig(Annes et al., 2012). This indicates that themTOR
pathway has a cross-species conserved element. To test this possibility of
rapamycin effect on primary cilia, we use both pig and rodent cultured cells.
Therefore, our hypothesis is that rapamycin will alter cilia length and function in
porcine renal epithelial and mouse vascular endothelial cells.
Materials and Methods
Cell culture
Porcine renal epithelial cells from proximal tubule (LLCPK) and mouse vascular
endothelial (ET) cells were cultured to a confluent monolayer in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS)
at 37 ◦C in 5% CO2. For our cell proliferation studies,mouse inner medullary collecting duct (mIMCD) cells were cultured using the same conditions as mentioned above. The generations of LLCLPK, ET and mIMCD cells have been previously described (Hull et al., 1976, Nauli et al., 2008, Rauchman et al.,
1993).Once confluent, cultured cells were incubated with media containing 2%
FBS. We used less serum at this time to further induce cell differentiation. Fully
differentiated cells tend to have optimal cilia length, and changes in cilia length
can be measured more consistently. In some cases, the media contained different
concentrations of rapamycin (0.01, 0.1, 1 and 10 μM) for 20 hours. For control
experiments, vehicle alone was added to cells in the same manner and volume.
Cilia length analysis
Primary cilia consist of acetylated microtubule structures and were measured by
direct immunofluorescence with anti-acetylated α-tubulin staining in the
absence or presence of 20-hour incubation with 1µM rapamycin. The cells were
fixed for 10 minutes (4% paraformaldehyde/2% sucrose in PBS) and
permeabilized for 5 minutes (10% triton X-100). Acetylated α-tubulin (1:10,000
dilution, Sigma Aldrich,St. Louis, MO) and fluorescein isothiocyanate (FITC)conjugated (1:1000 dilution, Vector Labs Burlingame, CA) antibodies were each
incubated with the cells for 1 hour at 37◦C. Slides were then mounted with DAPI
(Southern Biotech, Birmingham, AL) hard set mounting media.Nikon Eclipse
Ti-E inverted microscope with NIS-Elements imaging software (version 4.30)
was used to capture images of primary cilia. Automated image acquisition was
conducted in 100X magnification fields and Z-stacks (0.1 µm slices) to create a
large 3D image. This was done to select cilia from a confluent monolayer since it
mimics the physiological structure of the epithelial and endothelial cells.
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Cytosolic calcium analysis
Cells were grown on glass-bottom plates to enable live microscopy imaging.
After incubation for 20-hour without or with 1µM rapamycin, cells were loaded
with 5 µM Fura2-AM (TEFLabs, Austin, TX) at 37◦C for 30 min. Cells were then
washed with DPBS (Dulbecco's Phosphate-Buffered Saline) and observed under
a 40× objective lens with a Nikon Eclipse Ti-E microscope controlled by Elements software. Cytosolic calcium was observed by recording calcium-bound
Fura excitation fluorescence at 340/380 nm and emission at 510 nm. Baseline calcium was observed for 2 minutes prior to data acquisition. Fluid-shear stress was
then applied to cells utilizing an Instech P720 peristaltic pump with an inlet and
outlet setup. The fluid was perfusedon the glass-bottom plates at shear stress of
0.2, 0.6 or 1.0 dyne/cm2 for epithelial cells and 2.0, 5.0 or 8.0 dyne/cm2 for endothelial cells.After each experiment, the maximum calcium signal was obtained
by perfusion of ATP (10µM) to confirm cell viability.Conditions for all experiments were maintained at 37◦C and 5% CO2 in a stage top cage incubator
(okoLab, Burlingame, CA). Calcium analysis was then followed a standard calculation as previously described (Upadhyay et al., 2014).
Cell cycle analysis
To investigate a possibility of rapamycin effect on cell growth, cells were harvested with and without1 μM rapamycin treatment. Cells were then fixed using
70% ethanol and incubated with propidium iodide (PI, 50 μg/ml), a DNAintercalating fluorescent molecule, for 30 min at 37◦C. To investigate cell cycle
more accurately, cells were synchronized by physical separations based on their
size and density. Cells were then grow for 36 hours and incubated with 10
μMBrdU (Invitrogen, Eugene, OR) for 1 hour at 37 ◦C and 5% CO2. Cells were
trypsinized and fixed with 70% ethanol overnight at -20°C. After fixation the
cells were permeabilized with 0.5% triton X-100 in PBS for 10 minutes. To denature DNA, a solution of 4N HCl with 1.0 % triton X-100 in ddH2O was used to
incubate the cells for 20 minutes at room temperature followed by a quick neutralization step using 0.1M sodium borate, pH 8.5. The cells were then treated
with Alexa 488 conjugated BrdU antibody (Invitrogen, Eugene, OR) at 1:25 dilution in PBS for 1 hour at at 37 ◦C. Samples were stored in the dark for the antibody incubation and all steps afterwards. The cells were then stained with 50
μg/ml PI for 30 min at 37 ◦C. Cell analysis was carried out with flow
cytometryBDFacsverse with BD FACsuite software.
Statistical analysis
Cilia length measurement consisted of n = 50-70 for each slide preparation, and a
total of 4 slideswasused in each group. Cytosolic calcium measurements consisted of n = 50 for each plate, and a total of 4 plates were used in each group.Cell
cycle analysis consisted of n = 4 and a sample size of 10,000 for each individual
experiment. All data are reported as mean ± standard error of mean with statistical power greater than 0.8 at p < 0.05.Data were analyzed utilizing ANOVA test
followed by Tukey post-test for multiple groups. Analysis of data was performed
with Prism GraphPad 5 software.
Results
To find concentration of rapamycin that might affect the length of primary cilia,
we carried out initial screening of rapamycin at a range of 0 mM to 10 mM in
renal epithelial cells. Cilia length analysis using immunoflorescent-staining of
acetylated α-tubulin shows the changes in cilia length distribution with different
rapamycin concentrations (Figure 1). Treatment with rapamycin at a concentration of 1.0 μM gave an optimal and consistent percentage of cilia with longer
lengths. Concentration of 1.0 μM was therefore selected for the rest of our experiments. We next confirmed the effect of rapamycin by acquiring the images
three-dimensionally for a more precise measurement to account for cilia that
appear at different focal planes (Supplemental Movie). In renal epithelial cells,
average cilia length was 7.05 ± 0.15 μm. When treated with rapamycin (1.0 μM)
for 20 hours, cilia length increased to 9.90 ± 0.33 μm showing an increase of
almost 3.0 μm. In vascular endothelial cells the effect of rapamycin on cilia
length was more pronounced. Compared to an average cilia length of 3.67 ± 0.04
μm in control endothelial cells rapamycin treatment increased cilia length to 6.94
± 0.16 μm, almost twice the length of normal cilia. Statistical analysis showed
significant differences in cilia length between the control vs. rapamycintreatment in epithelial and endothelial cells (Figure 2).
As previous studies have shown, primary cilia responding to fluid flow can be
observed through an influx of extracellular calcium (Siroky et al., 2006, Liu et
al., 2005). For live-cell acquisition during flow experiments, cytosolic calcium
level was measured with fura-2-AM a cell permeant calcium-specific indicator.
After baseline measurement, cells were subjected to their optimal shear-stress
and fura-2 fluorescence was captured at 510 nm. We observed an increase in the
cytosolic calcium levels, which can be seen in representative pseudocolored
images which correlate to cytosolic calcium levels (Figure 3). Our data show
that rapamycin treatment enhances calcium influx after induction of shear stress
in epithelial and endothelial cells (Figure 4A). Comparisons of peak calcium levels between control and rapamycin treated cells show significant increase in the
maximum levels of calcium that is achieved upon exposure to shear stress (Figure 4B).
Previous studies in our laboratories have indicated a correlation between cilia
length and its ability to sense shear stress (Abdul-Majeed et al., 2012, Upadhyay
et al., 2014). To examine if increase in cilia length from the rapamycin-treated
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cells would result in a greater sensitivity to fluid shear-stress, we used lower levels of shear stress and measured intracellular calcium influx in response to the
simulation. In our epithelial cells we chose a physiologically relevant range of
shear stress from 0.2 to a maximum of 1.0 dyne/cm2 (Figure 5A). In our control
cells we observe a calcium response starting at shear-stress levels ≥ 0.6 dyne/cm2.
At the same level of shear-stress, rapamycin treated epithelial cells show a much
higher influx of calcium and the calcium response is even present in a low shearstress of 0.2 dyne/cm2 which is not seen in control cells. However, the trend of
increased shear-stress inducing higher cytosolic calcium is seen in control cells,
consistent with the idea that cells respond better toan optimal shear-stress level
(Doerr et al., 2016, Nauli et al., 2008). This trend is also seen in endothelial cells,
which line the vasculature and are exposed to higher levels of shear stress in vivo
(Figure 5B). In our experiments with endothelial cells we chose to observe the
effect of physiologically relevant range of shear stress starting from 2 dyne/cm2to
a maximum of 8 dyne/cm2. Rapamycin treated cells were able to initiate a calcium response at shear stress ≥ 2.0 dyne/cm2 while control cells only responded
at shear stress ≥ 6.0 dyne/cm2. Even the cytosolic calcium increase was reduced
in control cells at different shear stress compared to rapamycin treated cells. Significant differences were observed between the shear stress-induced calcium
influx in both epithelial and endothelial cells when compared to their respective
control at varying levels of shear stress (Figure 5C).
Different models have been proposed for mTOR as a central regulator of cell
metabolism, growth, proliferation and survival. Studies have shown that inhibition of the mTOR pathway using rapamycin leads to a G0/G1-phase arrest in
yeast cells and mammalian lymphocytes (Fingar et al., 2004). It is widely known
that cilia formation and elongation occurs during the resting phase. The same
effect can be achieved by serum starvation, which results in cilia growing to their
full extent(Nauli et al., 2013). With rapamycin known to be an anti-proliferative
agent, we next examined the effect of rapamycin treatment on the cell growth distribution and whether growth arrest played a role in ciliary length increase. Significant differences were observed only in epithelial cells, where a higher percentage of cells were non-dividing compared to control (Figure 6). This same
effect was not observed in endothelial cells and might be attributed to the different in species (pig vs. mouse) or cell types (renal epithelia vs. vascular
endothelia).
To investigate the possibility of species or cell type contribution on the differential effect of rapamycin, we included mouse renal epithelial cells in our study.
BrdUwas used to more specifically label dividing cells, and it was coupled with
propidium iodide to stain total DNA in each cell. Consistent with previous study,
we observed significant effect of rapamycin in cell cycle. However, the effect of
rapamycin was only seen in porcine renal epithelial cells (Figure 7A) and not in
mouse renal epithelial cells (Figure 7B) or mouse vascular endothelial cells (Figure 7C). A previous study has shown that inhibition of discrete mTOR downstream effectors may also be dependent on rapamycin concentration. The report
suggests that a higher dose in the micromolar range of rapamycin was needed to
completely block G1 cell cycle progression and that too was dependent on the
sensitivity of the cells to rapamycin (Chatterjee et al., 2015). Thus, a potential
effect of rapamycin to reduce cell division in endothelial cells remains possible at
a higher concentration.
Discussion
Primary cilia are critical sensory organelles that respond to flow in lumen-lining
cells by initiating calcium influx into the cytoplasm. Using cytosolic calcium as
a readout of ciliary function Upadhyay et. al. were able to show that cilia sensitivity to fluid-shear stress correlates with the length of cilia (Upadhyay et al.,
2014). Our current studies indicate that rapamycin increases cilia length and
enhances cilia sensitivity. We therefore hypothesize that rapamycin might
increase cell sensitivity in response to fluid-shear stress through cytosolic calcium increase (as a readout) by enhancing cilia length and function. This, in turn,
might have clinical relevant in preserving organ functions (Figure 8). In particular, many rodent models with no or short cilia length result in ciliopathy phenotypes, including cystic kidney, developmental delay, intellectual disability, and
many others (Wallmeier et al., 2016, Ha et al., 2016, Lu et al., 2016, Zhang et al.,
2011).Because cilia formation and function have been associated with cellcycle(AbouAlaiwi et al., 2011, Plotnikova et al., 2009), we also investigated the
roles of rapamycin in cell division. Our studies indicate that the effect of
rapamycin on cell cycle may be species-dependent, although we cannot rule out
that different species may have different sensitivity toward rapamycin.
Novel insights provided by in vitro studies and animal models may be utilized
into designing treatments that improve ciliary structure/function. In the case of
PKD, treatment strategies have included drugs that target disrupted mechanisms
such as intracellular calcium, cAMP, CFTR chloride channels, or mTOR signaling(Torres, 2010, Yang et al., 2008, Magenheimer et al., 2006). Previous studies
show that the mTOR pathway is aberrantly activated in PKD cells (Pei, 2010,
Shillingford et al., 2006, Shillingford et al., 2010).mTOR is a serine/threonine
kinase that provides the catalytic subunit for two distinct multi-protein complexes, mTORC1 and mTORC2. mTORC1 acts as metabolic sensor and is regulated by availability of amino acids, growth factors and energy stores. Activation
of mTORC1 promotes both cell growth and proliferation. mTORC2 has been
shown to function as an important regulator of the cytoskeleton organization, cell
survival and polarity (Lieberthal and Levine, 2012, Loewith et al., 2002). West-
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ern blot analysis of orthologous animal models and humans with PKD show
increased activation, i.e. phosphorylation of mTORC1 downstream targets and
the 4E-BPs(Zafar et al., 2010). Rapamycin binds to FKBP12 and can inhibit both
mTORC1 and, to a lesser extent, mTORC2 signaling(Zeng et al., 2007,
Sarbassov et al., 2006).Rapamycin may induce glomerulonephritis and
intratubular cast formation in protein overload nephropathy (Coombes et al.,
2005, Marti and Frey, 2005). Nonetheless, treatment with rapamycin slows
down cyst progression and improves renal function in animal models of
PKD(Shillingford et al., 2006, Tao et al., 2005, Wahl et al., 2006, Zafar et al.,
2010).Although the effect of reducing cyst burden by rapamycin has not been
consistent in all animal models or in trials with PKD patients, substantial evidence linking aberrant mTOR activity to cystogenesis suggests that mTOR
might be one of complex intertwined pathways in the pathogenesis of PKD and
other ciliopathies.
We use both porcine and mouse cells in the present studies. The porcine cells
were generated previously and have been used because humans are more closely
related to pigs than to rodents, particularly with regard to renal physiology
(Heussner and Dietrich, 2013, Hull et al., 1976).These porcine cells also display
inherent characteristics of structural organization and transepithelial transport
functions similar to those renal epithelia observed under in vivo conditions
within the proximal tubules. Thus, it is thought that these porcine cells might represent an alternative to human primary cells. The mouse cells were generated previously from aorta and retain its vascular properties and endothelial markers
(Abou Alaiwi et al., 2011, Brookes et al., 2013, Nauli et al., 2008). The functional studies of these cells have also shown that these cells retain cellular
responses to various mechanical forces and pharmacological agents. In addition, these cells have normal directional migration, monolayer permeability and
cytoskeletal organization (Jones et al., 2012).
Endothelial cells, which line the inner lumen of blood vessels, depend on cilia to
sense the shear stress. Observations of vascular endothelial cells lacking cilia
show that without functional cilia, there is no calcium influx in response to fluid
flow (Nauli et al., 2008). This prevents the vasculature to adapt with variable
blood flow levels since the bending of primary cilia also regulates the production
of nitric oxide (NO), an important vasodilator (Nauli et al., 2008). Abnormalities
in cilia function have been associated with defective NO production resulting in
hypertension (Rahbari-Oskoui et al., 2014), vascular aneurysm (Aboualaiwi et
al., 2014) in addition to cyst formation in the kidneys (Ecder and Schrier, 2009).
In our study, we observedthat rapamycin has an effect in the cilia of porcine epithelial and mouse endothelial cells. The results show that in addition to increasing cilia length, rapamycin-treated cells showed a higher cytosolic calcium
response when challenged to fluid flow. This is in agreement with previous studies done with dopaminergic agents that enhanced cilia length and function(Upadhyay et al., 2014).Typically, ciliogenesis occurs during the G0/G1
phase when the centriole becomes the basal body that serves as a foundation for
attachment of ciliary subunits. With the help of interflagellar transport (IFT) proteins the cilia keeps elongating till it reaches its determined length. This induction of optimum ciliary length can be observed in cilia of cells subjected to serum
deprivation to induce a G0/G1 arrest.Because rapamycin is an antiproliferative
agent, we did cell cycle analysis to determine if our concentration of 1 μM
rapamycin caused any changes to the cell cycle distribution, which could have
affected our ciliary length observations. Our FACS results show than only porcine epithelial cells show a slight increase population of cells in the G0/G1 phase.
To examine whether this was a cell line specific or species-specific response we
usedmouse renal epithelia and observed no significant changes in cell cycle distribution.
In healthy renal epithelia or vascular endothelia, primary cilia bend when
exposed to physiological flow and initiate an increase in cytosolic calcium in
addition to initiating modulation of other signaling pathways important for normal tissue homeostasis. Using influx of extracellular calcium as a marker of cilia
function in response to fluid flow, we were able to observe an increase in ciliary
function with rapamycin treatment.
Rapamycin has been effective in decreasing cyst progression but its effect on the
cilia structure/function has not received much attention. Primary cilia have been
established as important flow sensing organelles and shortened cilia fail to translate the mechanical stimulation to downstream intracellular responses.Recently
studies showed that primary cilia can regulate mTOR activity(Aznar and
Billaud, 2010, Boehlke et al., 2010). MDCK cells grown under permanent fluid
flow for several days showed decreased mTOR activity compared to cilia-less
Kif3a knockdown cells. This in vitro study demonstrated that flow-induced bending of the cilium activates Lkb1-mediated phosphorylation of AMPK at the basal
body of the cilia, inhibiting mTORC1 activity and regulating cell size (Boehlke
et al., 2010). The ability of cilia to silence mTOR and the reciprocal increase in
cilia length by mTOR inhibition indicate that the cilia-mTOR pathway may have
much more in common than previously thought. Although the rationale of
rapamycin treatment for PKD or TSC hinges on the aberrant mTOR pathway, our
study shows that rapamycin plays a role in cilia length/function providing tentative evidence that rapamycin could potentially be used as a ciliotherapy. In
healthy cells there is a defined range of cilia length and it is dependent on the
shear stress experienced by the system. In places with high levels of shear stress,
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such as the vasculature, cilia are usually shorter. In the renal nephron where the
filtrate flows comparatively slowly, the epithelial cells have longer cilia that can
extend outward into the lumen to sense flow, which is unhindered by the drag
forces near the wall.
Our studies offer a fundamental idea that rapamycin has an effect on primary
cilia. Whether effect of rapamycin on cilia is direct or indirect, future studies are
warranted for a better in-depth understanding to extrapolate the results from animal cells into clinical practice. Importantly, our results require further research
to understand the pathways connecting the primary cilium, mTOR signaling and
cystogenesis in ciliopathies.
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Figure legends

Figure 3

Figure 1

Figure 3. Fluid-shear stress induces calcium influx.
Representative Fura images at different time points from each groupare shown,
and the arrow indicates the start of fluid flow. Color bars indicate cytosolic calcium levels from low (green) to high (high).
Figure 4a

Figure 4b

Figure 1. Aninitial screening indicates that rapamycin might increase the length
primary cilia length in renal epithelial cells.
Cells were treated with various concentrations of rapamycin (0 to 10 mM).
Length measurements were made from images taken at one single plane in triplicate. Cilia length was grouped in a discrete range, and percent distribution was
tabulated for each rapamycin concentration.
Figure 2
Figure 4. Flow-induced calcium influx into the cytoplasm is increased in cells
treated with rapamycin.
(A) Intracellular calcium was measured in response to fluid-shear stress. The
arrows indicate start of fluid flow. N=50 cells for each preparation, and a total of
4 preparations was used in each group. (B) Cilia function is assessed as peak of
calcium influx in response to fluid-shear stress.Average peak calcium levels in
control and rapamycin-treated cells are shown. Calcium peak is used to determine cilia function in response to fluid-shear stress. Cilia function is significantly greater inrapamycin-treated than in control cells. N=50 cells for each
preparation, and a total of 4 preparations was used in each group. * = p<0.05 compared to corresponding controls.

Figure 2.Treatment with rapamycin (1μM) increases primary cilia length in epithelial and endothelial cells.
(A) Cells were stained with ciliary marker acetylated-α-tubulin (green) and a
nuclear marker (DAPI; blue). Rapamycin treatment increased cilia length in both
cell lines. Each image was compiled from different z-stack captures. (B) Cilia
length was significantly longer in rapamycin-treated cells, with a two-fold
increase observed in endothelial cells. N=50-70 for each slide preparation, and a
total of 4 slides was used in each group. * = p<0.05 compared to corresponding
controls.
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Figure 5a

Figure 5. Rapamycin-treated cells show higher calcium influx in response to
increasing various shear-stress forces.

Figure 5b

In the time-lapse graph, baseline calcium levels were measured, and shear stress
was applied at ~10 seconds (arrows). For epithelial cells a physiologically relevant range of 0-1.0 dyne/cm2 was used and for endothelial cells which experience
higher ranges maximum shear stress used was 8 dyne/cm2. (A) In renal epithelial
cells, rapamycin treated cells showed higher levels of peak calcium in response
to shear stress of varying magnitude. A shear stress of 0.2 dyne/cm2 was enough
to cause calcium influx in rapamycin-treated cells. (B) Same effect was observed
in vascular endothelial cells where rapamycin treatment increased the shear
stress-induced calcium influx compared to control cells. (C) Peak calcium levels
are shown on the graph at different levels of shear stress. In epithelial cells, significant increase in calcium influx was observed at shear stress levels ≥ 0.6
dyne/cm2 in rapamycin-treated vs. control cells. Endothelial cells also show significant increase in calcium influx when exposed to different levels of shear
stress. For each calcium measurement, and a total of 4 experiments with N=50
for each was used. * = p<0.05 compared to corresponding controls.
Figure 6

Figure 6. Treatment with rapamycin shows a minimal effect on the cell growth.
Cells were stained with propidium iodide (PI), a DNA intercalating agent, for
flow cytometry analysis. (A) Epithelial cells showed a slight but significant
increase in cells at the resting (G0) stage and lower percentage of cells undergoing mitosis when treated with rapamycin. (B) For endothelial cells, no significant
variation in cell cycle was seen in rapamycin-treated cells compared to control.
*= p<0.05 compared to corresponding controls.
Figure 5c
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Figure 7

Figure 7. Treatment with rapamycin causes G1 phase arrest in porcine cells but
not in mouse-derived cells.
In our cell cycle assay, BrdU incorporation was used to resolve cell cycle phases.
(A) In epithelial cells treated with rapamycin the cell population was shifted
more towards a G0/G1 phase by a significant amount. The rapamycin treated
cells also had lower levels of BrdU incorporation indicating a G1 phase arrest.
The population of cells in S-phase were found to be significantly reduced after
rapamycin treatment. For mice epithelial (B) and endothelial (C) cells, no significant variation in cell cycle was seen in rapamycin-treated cells compared to
control. * = p<0.05 compared to corresponding controls.
Figure 8
Hypothetical Model:

Figure 8. Hypothetical working model of rapamycin on cilia length and function.
Rapamycin increases cell sensitivity in response to fluid-shear stress. A greater
sensitivity or response to shear stress is postulated to be a result of longer primary
cilia. This, in turn, increases cilia function as denoted by an increase in shearinduced cytosolic calcium flux. Optimal length and function of primary cilia are
thought to be required for proper architecture of tissue maintainane.
Supplemental Movie
Shown here is a representative approach of our data analysis on cilia length. To
enable a more accurate measurement of cilia, the images of primary cilia (green)
and nucleus (blue) were taken three-dimensionally. This allows measurement of
cilia that are within a single focal plane and at a different focal plane.
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